67
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation

, , , , &
Pages 283-287 | Published online: 11 Feb 2014

References

  • BoyerEWShannonMThe serotonin syndromeN Engl J Med2005352111112112015784664
  • DunkleyEJIsbisterGKSibbrittDDawsonAHWhyteIMThe Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicityQJM200396963564212925718
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR)Washington DCAmerican Psychiatric Association2000795798
  • IsbisterGKBuckleyNAWhyteIMSerotonin toxicity: a practical approach to diagnosis and treatmentMed J Aust2007187636136517874986
  • HerrKDNemeroffCBParoxetineSchatzbergAFNemeroffCBThe American Psychiatric Publishing Textbook of Psychopharmacology3rdArlington, VAAmerican Psychiatric Publishing2004259281
  • OdagakiYToyoshimaR5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranesClin Exp Pharmacol Physiol2007345–646246617439416
  • IshibashiTOhnoYPerospirone hydrochloride: the novel atypical antipsychotic agent with high affinities for 5-HT2, D2 and 5-HT1A receptorsBiogenic Amines200418307311
  • SchotteAJanssenPFGommerenWRisperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor bindingPsychopharmacology (Berl)19961241–257738935801
  • Newman-TancrediAThe importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectivesCurr Opin Investig Drugs2010117802812
  • MeltzerHYSumiyoshiTDoes stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?Behav Brain Res200819519810218707769
  • SatoSMizukamiKMoroKTanakaYAsadaTEfficacy of perospirone in the management of aggressive behavior associated with dementiaProg Neuropsychopharmacol Biol Psychiatry200630467968316581169
  • SmithLMPeroutkaSJDifferential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndromePharmacol Biochem Behav1986246151315192942947
  • NisijimaKShiodaKIwamuraTNeuroleptic malignant syndrome and serotonin syndromeProg Brain Res20071628110417645916
  • Abdel-FattahAFMatsumotoKel-HadyKAWatanabeH5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated ratsPharmacol Biochem Behav19955223793848577805
  • NisijimaKYoshinoTYuiKKatohSPotent serotonin (5-HT) (2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndromeBrain Res20018901233111164765
  • SlettedalJKNilssenDOMagelssenMLøbergEMMaehlenJBrain pathology in fatal serotonin syndrome: presentation of two casesNeuropathology201131326527020880320
  • DalpiazAGessiSBoreaPAGilliGBinding thermodynamics of serotonin to rat-brain 5-HT1A, 5HT2A and 5-HT3 receptorsLife Sci19955712PL141PL1467674802
  • TanakaANagamatsuTYamaguchiMMyoclonus after dextromethorphan administration in peritoneal dialysisAnn Pharmacother2011451e121228393
  • KalueffAVLaPorteJLMurphyDLPerspectives on genetic animal models of serotonin toxicityNeurochem Int2008524–564965817935833
  • LauterbachECFluoxetine, buspirone, myoclonus, and dystoniaAm J Psychiatry19951521116977485652
  • ManosGHPossible serotonin syndrome associated with buspirone added to fluoxetineAnn Pharmacother2000347–887187410928399
  • OdagakiYAtypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?Curr Drug Saf200941849319149529
  • TrivediMHFavaMWisniewskiSRSTAR*D Study TeamMedication augmentation after the failure of SSRIs for depressionN Engl J Med2006354121243125216554526
  • CarpenterLLYasminSPriceLHA double-blind, placebo-controlled study of antidepressant augmentation with mirtazapineBiol Psychiatry200251218318811822997
  • WorthingtonJJ3rdKinrysGWygantLEPollackMHAripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patientsInt Clin Psychopharmacol200520191115602109
  • HeinrichTBöttcherHGerickeRSynthesis and structure – activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitorsJ Med Chem200447194684469215341484
  • Bang-AndersenBRuhlandTJørgensenMDiscovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorderJ Med Chem20115493206322121486038